SBI Securities’s Anixa Biosciences ANIX Stock Holding History

SBI Securities’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$196	Sell	70 -153	-69%	-$425	﹤0.01%	3332
2026 Q1	$575	Hold	223	–	–	﹤0.01%	2840
2025 Q4	$696	Sell	223 -9	-4%	-$37	﹤0.01%	2756
2025 Q3	$766	Buy	232 +1	+0.4%	+$3	﹤0.01%	2802
2025 Q2	$762	Hold	231	–	–	﹤0.01%	2792
2025 Q1	$661	Hold	231	–	–	﹤0.01%	2756
2024 Q4	$536	Buy	+231	New	+$717	﹤0.01%	2867

Other funds holding ANIX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

SBI Securities's ANIX Position: Q2 2026 in Review

SBI Securities reduced its Anixa Biosciences (ANIX) stake by 69% in Q2 2026, selling an estimated $425 and leaving 70 shares worth $196. The position accounts for ﹤0.01% of the portfolio, ranked #3332.

SBI Securities first reported a position in ANIX in Q4 2024 and has held it in 7 quarters since. The position peaked at $766 in Q3 2025. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

SBI Securities held 70 shares of Anixa Biosciences worth $196 as of Q2 2026.
SBI Securities sold 153 Anixa Biosciences shares in Q2 2026, an estimated $425.
Anixa Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3332 holding.
SBI Securities first reported a position in Anixa Biosciences in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Anixa Biosciences position peaked at $766 in Q3 2025.
62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.